Built to be flexible: GLP-1 coverage solutions | Episode 4 - Omada Horizon Series
What is the best GLP-1 benefits strategy? A flexible one.
The majority of employers consider managing GLP-1 coverage and cost important, but finding a financially sustainable path for access can be difficult. That’s why Omada is introducing GLP-1 Flex Care, a new offering that will support employers looking to increase access to GLP-1 medications for obesity.
Members who independently purchase GLP-1 medications through established cash-pay channels can now receive Omada's proven virtual care, including personalized coaching and lifestyle support, throughout their GLP-1 journey. They’ll also benefit from clinical evaluation, prescribing, and ongoing medical guidance and oversight.
Since members purchase the medications directly, employers can offer a structured GLP-1 option without taking on open‑ended medication spend.
GLP-1 Flex Care will be available for employers later in 2026. Want to learn more? https://www.omadahealth.com/omada-for-glp-1-medication-access
For members who independently purchase GLP-1 medications through established cash-pay channels, Omada can provide wraparound lifestyle support that’s proven to deliver outcomes—all in one place. At one year, outcomes included:
-
~2x greater average weight loss for GLP-1 members than real-world evidence with standard care
-
67% continued GLP-1 usage compared to 47-49% in real-world evidence
-
63% maintained or continued to lose weight post GLP-1 discontinuation
Want to learn more about Omada's Outcomes?
